Loading clinical trials...
Loading clinical trials...
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Conditions
Interventions
Oral testosterone undecanoate
Locations
27
United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Alabama Internal Medicine, PC
Birmingham, Alabama, United States
Medical Affliated Research Center, Inc.
Huntsville, Alabama, United States
Precision Trials/Valley Urologic Associates
Glendale, Arizona, United States
Premier Clinical Research Center
Phoenix, Arizona, United States
Precision Trials/Valley Urologic Associates
Phoenix, Arizona, United States
Start Date
January 1, 2013
Primary Completion Date
July 1, 2013
Completion Date
July 1, 2013
Last Updated
December 12, 2017
NCT02081300
NCT02715713
NCT00858650
Lead Sponsor
Clarus Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions